Jay A. Fishman Ltd’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $602K | Sell |
1,545
-60
| -4% | -$25.4K | 0.05% | 61 |
|
|
2026
Q1 | $760K | Sell |
1,605
-80
| -5% | -$40.3K | 0.07% | 54 |
|
|
2025
Q4 | $787K | Hold |
1,685
| – | – | 0.06% | 53 |
|
|
2025
Q3 | $718K | Sell |
1,685
-365
| -18% | -$141K | 0.06% | 54 |
|
|
2025
Q2 | $785K | Sell |
2,050
-25
| -1% | -$9.01K | 0.08% | 50 |
|
|
2025
Q1 | $717K | Sell |
2,075
-260
| -11% | -$83.6K | 0.08% | 53 |
|
|
2024
Q4 | $701K | Hold |
2,335
| – | – | 0.07% | 57 |
|
|
2024
Q3 | $949K | Hold |
2,335
| – | – | 0.09% | 46 |
|
|
2024
Q2 | $750K | Sell |
2,335
-25
| -1% | -$8.12K | 0.08% | 51 |
|
|
2024
Q1 | $787K | Sell |
2,360
-25
| -1% | -$7.64K | 0.09% | 51 |
|
|
2023
Q4 | $646K | Hold |
2,385
| – | – | 0.07% | 56 |
|
|
2023
Q3 | $587K | Hold |
2,385
| – | – | 0.07% | 59 |
|
|
2023
Q2 | $724K | Hold |
2,385
| – | – | 0.09% | 57 |
|
|
2023
Q1 | $629K | Hold |
2,385
| – | – | 0.08% | 59 |
|
|
2022
Q4 | $572K | Sell |
2,385
-225
| -9% | -$50.4K | 0.08% | 63 |
|
|
2022
Q3 | $480K | Sell |
2,610
-15
| -0.6% | -$2.99K | 0.07% | 67 |
|
|
2022
Q2 | $441K | Sell |
2,625
-50
| -2% | -$10.7K | 0.06% | 69 |
|
|
2022
Q1 | $670K | Hold |
2,675
| – | – | 0.07% | 65 |
|
|
2021
Q4 | $687K | Hold |
2,675
| – | – | 0.07% | 64 |
|
|
2021
Q3 | $649K | Sell |
2,675
-25
| -0.9% | -$6.11K | 0.08% | 63 |
|
|
2021
Q2 | $558K | Sell |
2,700
-325
| -11% | -$66.2K | 0.07% | 64 |
|
|
2021
Q1 | $570K | Hold |
3,025
| – | – | 0.08% | 66 |
|
|
2020
Q4 | $497K | Sell |
3,025
-100
| -3% | -$14.6K | 0.07% | 65 |
|
|
2020
Q3 | $390K | Hold |
3,125
| – | – | 0.06% | 70 |
|
|
2020
Q2 | $303K | Sell |
3,125
-2,200
| -41% | -$229K | 0.05% | 70 |
|
|
2020
Q1 | $568K | Buy |
5,325
+2,950
| +124% | +$382K | 0.06% | 80 |
|
|
2019
Q4 | $351K | Hold |
2,375
| – | – | 0.06% | 73 |
|
|
2019
Q3 | $286K | Sell |
2,375
-75
| -3% | -$9.69K | 0.05% | 72 |
|
|
2019
Q2 | $331K | Buy |
2,450
+250
| +11% | +$31.6K | 0.06% | 70 |
|
|
2019
Q1 | $287K | Buy |
2,200
+500
| +29% | +$67.2K | 0.05% | 79 |
|
|
2018
Q4 | $212K | Hold |
1,700
| – | – | 0.05% | 82 |
|
|
2018
Q3 | $237K | Buy |
+1,700
| New | +$212K | 0.04% | 83 |
|
|
2017
Q4 | – | Sell |
-5,625
| Closed | -$448K | – | 92 |
|
|
2017
Q3 | $448K | Hold |
5,625
| – | – | 0.09% | 67 |
|
|
2017
Q2 | $491K | Hold |
5,625
| – | – | 0.1% | 64 |
|
|
2017
Q1 | $501K | Sell |
5,625
-190
| -3% | -$15.8K | 0.11% | 65 |
|
|
2016
Q4 | $430K | Sell |
5,815
-25
| -0.4% | -$1.87K | 0.11% | 73 |
|
|
2016
Q3 | $442K | Buy |
5,840
+100
| +2% | +$7.66K | 0.11% | 65 |
|
|
2016
Q2 | $442K | Sell |
5,740
-150
| -3% | -$11.8K | 0.11% | 65 |
|
|
2016
Q1 | $460K | Buy |
5,890
+150
| +3% | +$10.5K | 0.12% | 66 |
|
|
2015
Q4 | $388K | Buy |
5,740
+200
| +4% | +$14K | 0.09% | 74 |
|
|
2015
Q3 | $429K | Buy |
5,540
+250
| +5% | +$22.1K | 0.1% | 71 |
|
|
2015
Q2 | $480K | Buy |
5,290
+550
| +12% | +$44.1K | 0.1% | 73 |
|
|
2015
Q1 | $357K | Buy |
+4,740
| New | +$340K | 0.07% | 84 |
|
Other funds holding HCA
Jay A. Fishman Ltd's HCA Position: Q2 2026 in Review
Jay A. Fishman Ltd reduced its HCA Healthcare (HCA) stake by 3.7% in Q2 2026, selling an estimated $25.4K and leaving 1,545 shares worth $602K. The position accounts for 0.05% of the portfolio, ranked #61.
Jay A. Fishman Ltd first reported a position in HCA in Q1 2015 and has held it in 43 quarters since. The position peaked at $949K in Q3 2024. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Jay A. Fishman Ltd held 1,545 shares of HCA Healthcare worth $602K as of Q2 2026.
- Jay A. Fishman Ltd sold 60 HCA Healthcare shares in Q2 2026, an estimated $25.4K.
- HCA Healthcare made up 0.05% of Jay A. Fishman Ltd's portfolio in Q2 2026, its #61 holding.
- Jay A. Fishman Ltd first reported a position in HCA Healthcare in Q1 2015 and has held it in 43 quarters since.
- Jay A. Fishman Ltd's HCA Healthcare position peaked at $949K in Q3 2024.
- 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Jay A. Fishman Ltd's 13F filing for Q2 2026, filed 29 Jul 2026.